Next Article in Journal
Idiopathic Exposed Bone Lesions of the Jaw
Previous Article in Journal
Photobiomodulation Therapy in the Treatment of Chronic Dysphagia Post Hormonal Therapy in a Breast Cancer Patient
Previous Article in Special Issue
Differential MicroRNA Expression of miR-21 and miR-155 within Oral Cancer Extracellular Vesicles in Response to Melatonin
Open AccessComment

Reply to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology

1
Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA
2
School of Medicine, National and Kapodistrian University of Athens, Alexandra General Hospital, 11528 Athens, Greece
3
Amgen Inc., Thousand Oaks, CA 91320, USA
*
Author to whom correspondence should be addressed.
Dent. J. 2019, 7(2), 54; https://doi.org/10.3390/dj7020054
Received: 31 January 2019 / Revised: 9 April 2019 / Accepted: 14 April 2019 / Published: 16 May 2019
  |  
PDF [355 KB, uploaded 29 May 2019]
  |  
Note: In lieu of an abstract, this is an excerpt from the first page.

Excerpt

We read the comment by Fusco et al [...] View Full-Text
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Raje, N.; Terpos, E.; Jandial, D.D. Reply to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology. Dent. J. 2019, 7, 54.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Dent. J. EISSN 2304-6767 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top